Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ViroCell Biologics and Great Ormond Street Hospital for Children Announce Partnership to Dislodge Gene and Cell Therapy “Logjam”
ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, and […]
Over One Million Invited For Covid Booster Jabs This Week
Invitations to book a Covid booster jab will be sent to one and a half […]
Gloucestershire Hospitals NHS Foundation Trust Selects Hyland Healthcare for Enhanced Content Services Infrastructure
NHS Digital Aspirant Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT) is moving a core element of its […]
Torbay and South Devon Selected for Pioneering Virtual HoloLens 2 Pilot
Torbay and South Devon NHS Foundation Trust (TSDFT), along with a small group of other […]
NHS Launches World’s Largest Trial of Cancer Blood Test
The NHS will today launch the world’s largest trial of a revolutionary new blood test […]
Additional £5.4 Billion for NHS Covid Response Over Next Six Months
The NHS will receive an extra £5.4 billion over the next six months to support […]
World-first Agreement Between Novartis and the NHS Enables Broad and Rapid Access to First-in-class Cholesterol-lowering Medicine Leqvio® ▼(inclisiran)
Novartis has reached a commercial agreement with the NHS in England as part of a […]
NHS to Diagnose Thousands of People with Rare Diabetes
Genetic testing on the NHS will spot a rare form of diabetes in thousands of […]
New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems
A new clinical trial to determine whether a third dose of vaccine will improve the […]
Groundbreaking Ceremony Marks Start of Work to Build Medical Student Accommodation
Just six weeks after planning permission was granted, construction work to build medical student accommodation […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more